Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Buy
13,315
+2,411
+22% +$282K 0.01% 400
2026
Q1
$1.31M Buy
10,904
+5,896
+118% +$681K 0.01% 386
2025
Q4
$527K Sell
5,008
-18,283
-78% -$1.72M ﹤0.01% 552
2025
Q3
$1.95M Sell
23,291
-13,901
-37% -$1.14M 0.01% 265
2025
Q2
$2.94M Buy
37,192
+3,135
+9% +$249K 0.03% 198
2025
Q1
$3.06M Sell
34,057
-44,359
-57% -$4.14M 0.06% 140
2024
Q4
$7.8M Buy
78,416
+65,711
+517% +$6.77M 0.13% 78
2024
Q3
$1.44M Sell
12,705
-1,337
-10% -$159K 0.03% 184
2024
Q2
$1.74M Sell
14,042
-42,025
-75% -$5.41M 0.05% 171
2024
Q1
$7.4M Sell
56,067
-69,425
-55% -$8.56M 0.24% 64
2023
Q4
$13.7M Buy
125,492
+122,609
+4,253% +$12.7M 0.54% 45
2023
Q3
$297K Buy
+2,883
New +$311K 0.04% 158
2023
Q2
Sell
-7,135
Closed -$759K 282
2023
Q1
$759K Sell
7,135
-6,837
-49% -$738K 0.1% 135
2022
Q4
$1.55M Buy
+13,972
New +$1.43M 0.22% 86

Other funds holding MRK

Marex Group's MRK Position: Q2 2026 in Review

Marex Group increased its Merck (MRK) stake by 22% in Q2 2026, buying an estimated $282K and bringing the position to 13,315 shares worth $1.71M. The position accounts for 0.01% of the portfolio, ranked #400.

Marex Group first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $13.7M in Q4 2023. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Marex Group held 13,315 shares of Merck worth $1.71M as of Q2 2026.
  • Marex Group bought 2,411 Merck shares in Q2 2026, an estimated $282K.
  • Merck made up 0.01% of Marex Group's portfolio in Q2 2026, its #400 holding.
  • Marex Group first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Marex Group's Merck position peaked at $13.7M in Q4 2023.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.